The rising prevalence in GLP-1 agonists for metabolic conditions has sparked a debate about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were exclusively https://larissaxtre758178.blogsvirals.com/39689403/glp-1-transdermal-delivery-systems-vs-oral-medications-which-best-for-you